Cargando…
Addressing Transcriptional Dysregulation in Cancer through CDK9 Inhibition
[Image: see text] Undermining transcriptional addiction, the dependence of cancers on selected transcriptional programs, is critically important for addressing cancers with high unmet clinical need. Cyclin-dependent kinase 9 (CDK9) has long been considered an actionable therapeutic target for modula...
Autores principales: | Toure, Mohammed A., Koehler, Angela N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035036/ https://www.ncbi.nlm.nih.gov/pubmed/36854448 http://dx.doi.org/10.1021/acs.biochem.2c00609 |
Ejemplares similares
-
Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition
por: Phadke, Manali, et al.
Publicado: (2017) -
CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90
por: Breuer, Denitra, et al.
Publicado: (2012) -
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016) -
Inhibition of cdk9 during Herpes Simplex Virus 1 Infection Impedes Viral Transcription
por: Ou, Mark, et al.
Publicado: (2013) -
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)